The Bayer Hemophilia Awards Program demonstrates Bayer's commitment to the bleeding disorders community and to advancing the state of the art of hemophilia care.
As Award decisions are taken by the independent Grants Review and Awards Committee and based on an applicant’s merit and eligibility, all decisions are final and not subject to appeal.
Early Career Investigator Award
This award will fund salary support and research funds for a junior faculty member who wishes to undertake a mentored basic and/or clinical research project in the bleeding disorders field. The applicant would be expected to dedicate a significant amount of time to the project. Examples of topics for research projects that might be considered for these awards include, but are not limited to:
- Clinical studies
- Properties and delivery of clotting factor proteins
- Assays and models
- Genetics and epidemiology
- Molecular aspects and mechanisms of clotting factor inhibitor formation.
The criteria by which applications will be judged include:
- Scientific merit of hypotheses and experimental approach
- Innovation in design, methodology and objectives
- Impact on future clinical or scientific understanding of bleeding disorders
- Mentor and research environment.
Early Career Investigator Awards will provide funding of US$100,000 annually for two years. Up to four new awards will be made each year. Part of the Award may fund salary support. The candidate must spend at least 25% of his/her time on the project in order to request salary support.